Core Viewpoint - Southbound funds have increased their holdings in Baize Medical (02609.HK) by 1.9632 million shares on February 23, indicating growing investor interest in the company [1] Group 1: Southbound Fund Activity - In the last 5 trading days, southbound funds have increased their holdings on 3 days, with a total net increase of 870,000 shares [1] - Over the past 20 trading days, there have been 11 days of net increases, totaling 7.2756 million shares [1] - Currently, southbound funds hold 75.3474 million shares of Baize Medical, representing 5.71% of the company's total issued ordinary shares [1] Group 2: Company Overview - Baize Medical Group primarily engages in investment and provision of medical-related services, focusing on oncology [1] - The company offers comprehensive oncology services, including screening, diagnosis, treatment, and rehabilitation [1] - Its business operations include hospital services, hospital management, supply of pharmaceuticals, medical devices, consumables, and other related services [1] - The company conducts cancer diagnosis, treatment, rehabilitation, and end-of-life care for patients, as well as early cancer screening, tumor vaccination, and health management services for other potential healthy populations [1] - Baize Medical primarily operates in the Chinese market [1]
佰泽医疗（02609.HK）：2月23日南向资金增持196.32万股